US Patent Number
8592482
Publication Date
11-26-2013
Abstract
Provided are methods and compositions for the treatment or prevention of ocular angiogenesis and neovascularization. Administration of inhibitors of the CCR3 receptor or its ligands eotaxin (CCL11), eotaxin-2 (CCL24) or eotaxin-3 (CCL26) inhibits ocular angiogenesis.
Assignees
University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
13/177,986
Filing Date
07/07/2011
Recommended Citation
Ambati, Jayakrishna, "CCR3 Inhibition for Ocular Angiogenesis and Macular Degeneration" (2013). Ophthalmology and Visual Science Faculty Patents. 3.
https://uknowledge.uky.edu/ophthalmology_patents/3
